Over the YEARS, the Medical Post has taken politicians to task for ineffective handling of health reform. To give them some credit, many political issues are complex with no clear-cut solution.
As the busy spring season winds down, there’s finally time to pause and reflect. I’d like to share a few of the things that surprised, delighted, and made a big impression on me in recent months.
Question: I am a clinical epidemiologist taking an initial look at generics vs. brand drugs for depression. There are some concerns in the published literature regarding determining the requirements for bio-equivalence of "highly-variable" (HV) drugs.
